Fundraising Fox

Biotech Growth Investors & VC Firms

747 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.

Catalyst Investments, L.P.
Tel AvivGrowth–Late Stage$1.5M – $5M
30 people
European Circular Bioeconomy Fund
BonnSeries A–Late Stage$5.5M – $16.5M
24 people
Scientifica Venture Capital
Pre-Seed–Growth
27 people
OMERS Private Equity Inc.
TorontoGrowth–Late Stage
20 people
First Analysis
ChicagoSeries A–Late Stage
23 people
Keio Innovation Initiative
TokyoSeed–Late Stage$1.5M – $64M
9 people
In-Q-Tel
TysonsSeed–Growth$100K – $2.5M
11 people
Argonautic Ventures
New YorkPre-Seed–Growth$5M
8 people
Booster Innovation Fund
WellingtonSeed–Growth
14 people
YuanBio Venture Capital
SuzhouSeed–Growth$3M – $73M
8 people
YFM Equity Partners
LondonSeed–Growth$3M – $15M
1 person
Signet Healthcare Partners
New YorkGrowth–Late Stage$10M – $50M
13 people
VenturEast
BangaloreSeed–Late Stage
12 people
Alta Partners
JacksonSeed–Growth$1M – $12M
10 people
Asabys Partners
MadridSeed–Growth
20 people
Arkin Capital
HerzliyaSeed–Late Stage
28 people
Blue Horizon Corporation
ZurichPre-Seed–Late Stage
2 people
i-nest capital
TokyoPre-Seed–Growth
7 people
Kaiser Permanente Ventures
San FranciscoSeed–Growth$2M – $5M
9 people
Telegraph Hill Partners
San FranciscoGrowth–Late Stage$2M – $8M
20 people
OneVentures
SydneySeed–Late Stage$3.3M – $13.2M
11 people
Windham Capital Partners
New YorkSeries A–Growth
17 people
Phoenix Venture Partners
San MateoPre-Seed–Growth$100K – $3M
16 people
Pontifax Venture Capital
HerzeliyaPre-Seed–Late Stage$6.3M – $128M
8 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.